Tumor growth regulation by modulation of basic fibroblast growth factor.
Gross
J L
JL
Du Pont Merck Pharmaceutical Co., Wilmington, DE 19880-0400.
Herblin
W F
WF
Eidsvoog
K
K
Horlick
R
R
Brem
S S
SS
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000627:therapeutic use; D002460:Cell Line; D004261:DNA Replication / Q000187:drug effects; D016222:Fibroblast Growth Factor 2 / Q000235:genetics* / Q000494:pharmacology* / Q000627:therapeutic use; D005910:Glioma / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage; D007167:Immunotherapy; D007700:Kinetics; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D051381:Rats; D011956:Receptors, Cell Surface / Q000235:genetics* / Q000378:metabolism; D017468:Receptors, Fibroblast Growth Factor; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D013370:Subrenal Capsule Assay; D013936:Thymidine / Q000378:metabolism; D014183:Transplantation, Heterologous; D014407:Tumor Cells, Cultured; D011798:Quinaldines
D000970:Antineoplastic Agents; D001713:Biphenyl Compounds; D016222:Fibroblast Growth Factor 2; D007074:Immunoglobulin G; D011956:Receptors, Cell Surface; D017468:Receptors, Fibroblast Growth Factor; D011994:Recombinant Proteins; D013936:Thymidine; C046943:brequinar; D011798:Quinaldines